ST Xue, B Zheng, SQ Cao, JC Ding, GS Hu, W Liu… - Molecular cancer, 2022 - Springer
Background Esophageal squamous cell carcinoma (ESCC) is a common invasive malignancy worldwide with poor clinical outcomes. Increasing amount of long non-coding …
WH Almalki - Pathology-Research and Practice, 2023 - Elsevier
Abstract The Emergence of Long Non-coding RNAs (lncRNAs) as Key Regulators in Diverse Biological Processes: A Paradigm Shift in Understanding Gene Expression and its Impact on …
Y Fang, S Huang, L Han, S Wang… - Cancer Management and …, 2021 - Taylor & Francis
Background Gastric cancer peritoneal metastasis has high mortality. At present, there is no effective way to cure the patients diagnosed with gastric cancer peritoneal metastasis due to …
L Wang, M Shang, Q Dai, P He - BMC bioinformatics, 2022 - Springer
Background More and more evidence showed that long non-coding RNAs (lncRNAs) play important roles in the development and progression of human sophisticated diseases …
Q Shen, R Wang, X Liu, P Song, M Zheng, X Ren, J Ma… - Cancers, 2022 - mdpi.com
Simple Summary Based on the latest research, cancer cells prefer glutamine to glucose. Therefore, it is more worthwhile to explore the regulatory mechanism of glutamine …
J Jia, H Li, J Chu, J Sheng, C Wang, Z Jia… - Journal of …, 2021 - ncbi.nlm.nih.gov
Background: Recent researches have pinpointed that long non-coding RNA (lncRNA) was tightly related to the carcinogenesis. However, the function of lncRNA in esophageal cell …
J Xue, Y Song, W Xu, Y Zhu - Cells, 2022 - mdpi.com
Background: Limited therapeutic options are available for advanced LUAD without driver gene mutations. Anti-CDK therapy has shown effectiveness in several kind of cancers …
F Wang, C Yuan, B Liu, YF Yang, HZ Wu - Journal of Translational …, 2022 - Springer
Background Breast cancer (BC) is one of the most common malignant tumors with the highest mortality in the world. Modern pharmacological studies have shown that Syringin …
ML Xu, TC Liu, FX Dong, LX Meng, AX Ling… - Aging (Albany NY …, 2021 - ncbi.nlm.nih.gov
Esophageal cancer is a malignant tumor with a five-year survival rate of less than 20%. Early diagnosis and exploration of esophageal cancer pathogenesis are of great significance for …